MEDIOS AG (ILM1.DE) Stock Fundamental Analysis
FRA:ILM1 - Deutsche Boerse Ag - DE000A1MMCC8 - Common Stock - Currency: EUR
Overall ILM1 gets a fundamental rating of 4 out of 10. We evaluated ILM1 against 25 industry peers in the Health Care Providers & Services industry. While ILM1 seems to be doing ok healthwise, there are quite some concerns on its profitability. ILM1 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ILM1 was profitable.
In the past year ILM1 had a positive cash flow from operations.
In the past 5 years ILM1 has always been profitable.
ILM1 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of 1.61%, ILM1 perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.89%, ILM1 is in line with its industry, outperforming 44.00% of the companies in the same industry.
ILM1 has a Return On Invested Capital (3.03%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ILM1 is below the industry average of 5.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROIC | 3.03% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
1.3 Margins
ILM1 has a worse Profit Margin (0.78%) than 60.00% of its industry peers.
ILM1's Profit Margin has declined in the last couple of years.
ILM1 has a worse Operating Margin (1.96%) than 76.00% of its industry peers.
In the last couple of years the Operating Margin of ILM1 has declined.
With a Gross Margin value of 8.91%, ILM1 is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
ILM1's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% |
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ILM1 is destroying value.
Compared to 1 year ago, ILM1 has more shares outstanding
Compared to 5 years ago, ILM1 has more shares outstanding
The debt/assets ratio for ILM1 is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.01 indicates that ILM1 is not in any danger for bankruptcy at the moment.
ILM1 has a Altman-Z score of 3.01. This is amongst the best in the industry. ILM1 outperforms 88.00% of its industry peers.
The Debt to FCF ratio of ILM1 is 8.28, which is on the high side as it means it would take ILM1, 8.28 years of fcf income to pay off all of its debts.
ILM1 has a Debt to FCF ratio of 8.28. This is in the better half of the industry: ILM1 outperforms 64.00% of its industry peers.
ILM1 has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
ILM1's Debt to Equity ratio of 0.37 is amongst the best of the industry. ILM1 outperforms 92.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Altman-Z | 3.01 |
ROIC/WACC0.47
WACC6.49%
2.3 Liquidity
ILM1 has a Current Ratio of 1.96. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
ILM1 has a Current ratio of 1.96. This is amongst the best in the industry. ILM1 outperforms 92.00% of its industry peers.
ILM1 has a Quick Ratio of 1.42. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
ILM1 has a better Quick ratio (1.42) than 88.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
ILM1 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.32%.
The Earnings Per Share has been decreasing by -5.00% on average over the past years.
ILM1 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.62%.
ILM1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.51% yearly.
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
3.2 Future
ILM1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.69% yearly.
The Revenue is expected to grow by 4.11% on average over the next years.
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue Next Year7.6%
Revenue Next 2Y6.04%
Revenue Next 3Y4.17%
Revenue Next 5Y4.11%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.46, ILM1 is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as ILM1.
Compared to an average S&P500 Price/Earnings ratio of 27.45, ILM1 is valued a bit cheaper.
The Price/Forward Earnings ratio is 8.54, which indicates a very decent valuation of ILM1.
96.00% of the companies in the same industry are more expensive than ILM1, based on the Price/Forward Earnings ratio.
ILM1 is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.46 | ||
| Fwd PE | 8.54 |
4.2 Price Multiples
ILM1's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ILM1 is cheaper than 80.00% of the companies in the same industry.
ILM1's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.07 | ||
| EV/EBITDA | 6.27 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILM1 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ILM1's earnings are expected to grow with 15.69% in the coming years.
PEG (NY)2.4
PEG (5Y)N/A
EPS Next 2Y21.1%
EPS Next 3Y15.69%
5. Dividend
5.1 Amount
No dividends for ILM1!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILM1 (7/4/2025, 7:00:00 PM)
12.66
-0.1 (-0.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap322.96M
Analysts85
Price Target28.08 (121.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-17.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.46 | ||
| Fwd PE | 8.54 | ||
| P/S | 0.17 | ||
| P/FCF | 12.07 | ||
| P/OCF | 9.54 | ||
| P/B | 0.62 | ||
| P/tB | 23.56 | ||
| EV/EBITDA | 6.27 |
EPS(TTM)0.59
EY4.66%
EPS(NY)1.48
Fwd EY11.71%
FCF(TTM)1.05
FCFY8.28%
OCF(TTM)1.33
OCFY10.48%
SpS74.93
BVpS20.26
TBVpS0.54
PEG (NY)2.4
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROCE | 4.99% | ||
| ROIC | 3.03% | ||
| ROICexc | 3.44% | ||
| ROICexgc | 14.41% | ||
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% | ||
| FCFM | 1.4% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexcg growth 3Y-0.85%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score4
Asset Turnover2.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Debt/EBITDA | 2.61 | ||
| Cap/Depr | 19.94% | ||
| Cap/Sales | 0.37% | ||
| Interest Coverage | 2.86 | ||
| Cash Conversion | 46.37% | ||
| Profit Quality | 179.07% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.01 |
F-Score4
WACC6.49%
ROIC/WACC0.47
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
Revenue Next Year7.6%
Revenue Next 2Y6.04%
Revenue Next 3Y4.17%
Revenue Next 5Y4.11%
EBIT growth 1Y25.3%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year110.41%
EBIT Next 3Y33.73%
EBIT Next 5Y29.68%
FCF growth 1Y140.67%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y136.45%
OCF growth 3Y6.19%
OCF growth 5YN/A